Fezagepras sodium
Fezagepras sodium (Setogepram sodium salt) is an orally bioavailable small molecule that acts as a GPR40 agonist and a GPR84 antagonist/inverse agonist. It exhibits anti-fibrotic, anti-inflammatory, and anti-proliferative properties, making it a useful research tool for studying metabolic and inflammatory diseases in both in vitro and in vivo models.
Product Specifications
CAS Number
1254472-97-3
Product Name Alternative
Fezagepras sodium, GPR40, PBI-4050 sodium, PBI-4050 sodium salt, Setogepram sodium, Setogepram sodium salt
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Purity
99.49% (May vary between batches)
Solubility
H2O:90 mg/mL (394.29 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (8.76 mM) ; DMSO:60 mg/mL (262.86 mM)
Smiles
CCCCCC1=CC (=CC=C1) CC (=O) [O-].[Na+]
Molecular Formula
C13H17NaO2
Molecular Weight
228.26
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Explore Other Products
Browse additional items from our catalog
GFAP, phosphorylated (Ser38) (Glial Fibrillary Acidic Protein) discontinued
GFAP, phosphorylated (Ser38) (Glial Fibrillary Acidic Protein) discontinued
Lentiviral mouse Zfp850 shRNA (UAS) - Lentiviral mouse Zfp850 shRNA (UAS) (25)
Recombinant Oryza sativa subsp. japonica Probable auxin efflux carrier component 6 (PIN6), partial
